Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Clinical Utility of Free Drug Monitoring

Amitava Dasgupta

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 40, Issue 10, Pages 986–993, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2002.172, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Most drugs are bound to serum proteins to a various degree. Only unbound or free drug is pharmacologically active. Usually total drug is measured for therapeutic monitoring because there is equilibrium between bound and free drugs, and concentration of free drug can be predicted from total drug concentration. However, under certain conditions this equilibrium is disturbed and the measured free drug concentration can be significantly higher than expected from total drug concentrations, especially for strongly protein-bound drugs. In such case a patient may experience drug toxicity even if the total drug concentration is within the therapeutic range. Conditions like uremia, liver disease and hypoalbuminemia can lead to significant increases in free drug concentration. Therefore, monitoring free phenytoin and free valproic acid is recommended in these patients. Drug-drug interactions can also lead to a disproportionate increase in free drug concentration. One strongly protein-bound drug can significantly displace another strongly proteinbound drug if both drugs share the same binding site. Several over-the-counter pain medications such as salicylate, naproxen, and ibuprofen can cause significant displacement of both phenytoin and valproic acid from albumin binding site. Interestingly, such interactions are absent in uremic patients. Elderly patients may have increased free phenytoin or valproic acid due to hypoalbuminemia. Elevated free phenytoin concentrations have also been reported in patients with AIDS. Although digoxin is 25% bound to protein, monitoring free digoxin is useful in patients with elevated endogenous digoxin-like immunoreactive substances or in patients overdosed with digoxin and being treated with digibind. Monitoring free digoxin can also eliminate interference of Chinese medicines Chan Su and Danshen in serum digoxin measurement by certain immunoassays. However, free drug monitoring is not a routine procedure in clinical laboratories due to technical difficulties and lack of established reference ranges for free drugs.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Daniela Milosheska, Iztok Grabnar, and Tomaž Vovk
European Journal of Pharmaceutical Sciences, 2015, Volume 75, Page 25
[2]
Kenji Ogata, Norito Takamura, Jin Tokunaga, Tetsuya Ikeda, Nao Setoguchi, Kazuhiro Tanda, Tetsuo Yamasaki, Toyotaka Nishio, and Keiichi Kawai
European Journal of Drug Metabolism and Pharmacokinetics, 2014
[3]
Matthew D. Krasowski and Gwendolyn A. McMillin
Clinica Chimica Acta, 2014, Volume 436, Page 224
[4]
Amina Haouala, Nicolas Widmer, Monia Guidi, Michael Montemurro, Serge Leyvraz, Thierry Buclin, Chin B. Eap, Laurent A. Decosterd, and Chantal Csajka
British Journal of Clinical Pharmacology, 2013, Volume 75, Number 4, Page 1007
[5]
Nao Setoguchi, Norito Takamura, Ken-ichi Fujita, Kenji Ogata, Jin Tokunaga, Toyotaka Nishio, Etsuo Chosa, Kazuhiko Arimori, Keiichi Kawai, and Ryuichi Yamamoto
Biopharmaceutics & Drug Disposition, 2013, Volume 34, Number 2, Page 125
[6]
Krystyna Sztefko and Patrycja Szybowska
International Journal of Endocrinology, 2012, Volume 2012, Page 1
[7]
Matthew D Krasowski and Louis E Penrod
BMC Medical Informatics and Decision Making, 2012, Volume 12, Number 1, Page 7
[8]
Dajana Vuckovic, Xu Zhang, Erasmus Cudjoe, and Janusz Pawliszyn
Journal of Chromatography A, 2010, Volume 1217, Number 25, Page 4041
[9]
Tarun Jain, Anil Bhandari, Veerma Ram, Sanjay Sharma, Manish Parakh, and Mahaveer Chand Parakh
Clinical Biochemistry, 2011, Volume 44, Number 8-9, Page 675
[10]
Johan K.M. Aps and Luc C. Martens
Forensic Science International, 2005, Volume 150, Number 2-3, Page 119
[11]
Steven Gabardi and Stuart Abramson
Medical Clinics of North America, 2005, Volume 89, Number 3, Page 649
[12]
Kenny Chan and Roy G. Beran
Seizure, 2008, Volume 17, Number 6, Page 572
[13]
Tsung O. Cheng
International Journal of Cardiology, 2007, Volume 121, Number 1, Page 9
[14]
Björn K.I. Meijers, Bert Bammens, Kristin Verbeke, and Pieter Evenepoel
American Journal of Kidney Diseases, 2008, Volume 51, Number 5, Page 839
[15]
Dajana Vuckovic, Inés de Lannoy, Brad Gien, Yingbo Yang, Florin Marcel Musteata, Robert Shirey, Leonard Sidisky, and Janusz Pawliszyn
Journal of Chromatography A, 2011, Volume 1218, Number 21, Page 3367
[16]
Manpreet K. Boparai and Beatriz Korc-Grodzicki
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, Volume 78, Number 4, Page 613
[17]
Sandrina L von Winckelmann, Isabel Spriet, and Ludo Willems
Pharmacotherapy, 2008, Volume 28, Number 11, Page 1391
[18]
Elena Llorente Fernández, Laura Parés, Iratxe Ajuria, Fernando Bandres, Bartomeu Castanyer, Francesc Campos, Carme Farré, Leonor Pou, Josep Maria Queraltó, and Jordi To-Figueras
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 4
[19]
Somashekar G. Krishna, Weizhi Zhao, Monica L. Grazziutti, Naveen Sanathkumar, Bart Barlogie, and Elias J. Anaissie
Cancer, 2011, Volume 117, Number 3, Page 648
[20]
Kenji Ogata, Norito Takamura, Jin Tokunaga, Keiichi Kawai, Kazuhiko Arimori, and Shun Higuchi
Journal of Pharmacy and Pharmacology, 2008, Volume 60, Number 1, Page 15
[21]
Jürgen Beer, Claudia Christina Wagner, and Markus Zeitlinger
The AAPS Journal, 2009, Volume 11, Number 1, Page 1
[22]
Sebastian Klammt, Steffen R. Mitzner, Jan Stange, Jan Loock, Uwe Heemann, Jörg Emmrich, Emil C. Reisinger, and Reinhard Schmidt
Liver Transplantation, 2008, Volume 14, Number 9, Page 1333
[23]
Jesús Hermida and J. Carlos Tutor
Journal of Pharmacological Sciences, 2005, Volume 97, Number 4, Page 489
[24]
Milin R. Acharya, Alex Sparreboom, Edward A. Sausville, Barbara A. Conley, James H. Doroshow, Jűrgen Venitz, and William D. Figg
Cancer Chemotherapy and Pharmacology, 2006, Volume 57, Number 3, Page 275
[25]
Gwen A McMillin, JoEtta Juenke, and Amitava Dasgupta
Therapeutic Drug Monitoring, 2005, Volume 27, Number 5, Page 630

Comments (0)

Please log in or register to comment.